A detailed history of Bank Of Montreal transactions in Eli Lilly & CO stock. As of the latest transaction made, Bank Of Montreal holds 1,812,982 shares of LLY stock, worth $1.64 Billion. This represents 0.74% of its overall portfolio holdings.

Number of Shares
1,812,982
Previous 1,916,339 5.39%
Holding current value
$1.64 Billion
Previous $1.12 Billion 26.26%
% of portfolio
0.74%
Previous 0.59%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $61.2 Million - $81.9 Million
-103,357 Reduced 5.39%
1,812,982 $1.41 Billion
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $99.9 Million - $118 Million
190,301 Added 11.03%
1,916,339 $1.12 Billion
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $98.8 Million - $136 Million
-227,219 Reduced 11.63%
1,726,038 $927 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $88 Million - $118 Million
250,760 Added 14.73%
1,953,257 $916 Million
Q1 2023

Jun 13, 2024

SELL
$310.63 - $364.82 $53.2 Million - $62.5 Million
-171,337 Reduced 9.45%
1,641,645 $564 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $48.3 Million - $56.3 Million
150,173 Added 9.67%
1,702,497 $623 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $9.98 Million - $11.4 Million
-33,669 Reduced 2.12%
1,552,324 $513 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $75.4 Million - $88.5 Million
270,379 Added 20.55%
1,585,993 $508 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $48.7 Million - $60.5 Million
-207,425 Reduced 13.62%
1,315,614 $382 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $150 Million - $187 Million
-668,859 Reduced 30.52%
1,523,039 $423 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $1.17 Million - $1.43 Million
5,261 Added 0.24%
2,191,898 $506 Million
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $395 Million - $511 Million
2,186,637 New
2,186,637 $501 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.